REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA
Clinical trials for REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial aims to bring targeted lymphoma drugs to minority patients
Disease control Recruiting nowThis phase 1 trial is testing a combination of two targeted drugs, zanubrutinib and sonrotoclax, in people from underrepresented racial and ethnic groups who have relapsed or refractory B-cell non-Hodgkin lymphoma. The study aims to see if this treatment is feasible and safe for …
Matched conditions: REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New drug combo aims to tackle tough lymphoma
Disease control Recruiting nowThis phase 2 trial is testing a combination of two targeted drugs, mosunetuzumab and polatuzumab vedotin, in about 41 adults with follicular lymphoma that has relapsed or is refractory. The drugs work by helping the immune system attack cancer cells and delivering a toxic agent d…
Matched conditions: REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC